Implantable cardioverter-defibrillator use among medicare patients with low ejection fraction after acute myocardial infarction

JAMA - Journal of the American Medical Association

Volumn 313, Issue 24, 2015, Pages 2433-2440

  Pokorney, Sean D ^a,b   Miller, Amy L ^c   Chen, Anita Y ^b   Thomas, Laine ^c   Fonarow, Gregg C ^d   De Lemos, James A ^e   Al Khatib, Sana M ^a,b   Peterson, Eric D ^a,b   Wang, Tracy Y ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE HEART INFARCTION; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENDER; HEART EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OBSERVATIONAL STUDY; PATIENT RISK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SURVIVAL; BLOOD; EPIDEMIOLOGY; HEART STROKE VOLUME; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SEX DIFFERENCE; UNITED STATES; UTILIZATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; STROKE VOLUME; TROPONIN; UNITED STATES;

EID: 84937597763     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.6409     Document Type: Article

References (27)

1. Roger VL, Go AS, Lloyd-Jones DM, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220.
2. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883.
3. Bardy GH, Lee KL, Mark DB, et al Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237.
4. Hohnloser SH, Kuck KH, Dorian P, et al DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481-2488.
5. Steinbeck G, Andresen D, Seidl K, et al IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361(15):1427-1436.
6. Yancy CW, Jessup M, Bozkurt B, et al Writing Committee Members; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-e327.
7. Narayanan K, Reinier K, Uy-Evanado A, et al. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community. Circulation. 2013;128(16):1733-1738.
8. Miller AL, Gosch K, Daugherty SL, et al. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry. Am Heart J. 2013;166(4):737-743.
9. Pham HH, Grossman JM, Cohen G, Bodenheimer T. Hospitalists and care transitions: the divorce of inpatient and outpatient care. Health Aff (Millwood). 2008;27(5):1315-1327.
10. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831-841.
11. Go AS, Mozaffarian D, Roger VL, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
12. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health Study. Circulation. 1995;91(6):1739-1748.
13. Chan PS, Nallamothu BK, Spertus JA, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2(1):16-24.
14. Hess PL, Grau-Sepulveda MV, Hernandez AF, et al Get With The Guidelines Steering Committee and Hospitals. Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure. J Cardiovasc Electrophysiol. 2013;24(6):664-671.
15. Peterson ED, Roe MT, Rumsfeld JS, et al. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2(5):491-499.
16. Peterson ED, Roe MT, Chen AY, et al. The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care. Heart. 2010;96(22):1798-1802.
17. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009;157(6):995-1000.
18. Roe MT, Chen AY, Thomas L, et al. Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score. Am Heart J. 2011;162(5):875-883.e1, e871.
19. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006;119(2):167.e17-167.e21.
20. Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592-599.
21. Yung D, Birnie D, Dorian P, et al. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation. 2013;127(24):2383-2392.
22. Pellegrini CN, Lee K, Olgin JE, et al. Impact of advanced age on survival in patients with implantable cardioverter defibrillators. Europace. 2008;10(11):1296-1301.
23. Krahn AD, Connolly SJ, Roberts RS, Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004; 147(5):837-840.
24. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001;134(6):451-458.
25. Sjöblom J, Muhrbeck J, Witt N, Alam M, Frykman-Kull V. Evolution of left ventricular ejection fraction after acute myocardial infarction: implications for implantable cardioverter-defibrillator eligibility. Circulation. 2014;130(9):743-748.
26. LaPointe NM, Al-Khatib SM, Piccini JP, et al. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circ Cardiovasc Qual Outcomes. 2011;4(2):146-151.
27. Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med. 2012;172(1):64-67.